SRPT financials
Sarepta Therapeutics (SRPT) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
SRPT income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $2.20B | $1.32B | -$657.77M | -$713.41M | -7.13 |
| 2024 | $1.90B | $1.58B | $218.08M | $235.24M | 2.34 |
| 2023 | $1.24B | $1.09B | -$267.82M | -$535.98M | -5.80 |
| 2022 | $933.01M | $793.02M | -$536.20M | -$703.49M | -8.03 |
| 2021 | $701.89M | $604.84M | -$459.71M | -$418.78M | -5.15 |
| 2020 | $540.10M | $476.72M | -$564.16M | -$554.13M | -7.11 |
- SRPT revenue was $2.20B in fiscal 2025, net income -$713.41M.
Updated 2026-11-03 12:36 UTC